Signaling in fibrosis: Targeting the TGFbeta, endothelin-1 and CCN2 axis in scleroderma

Frontiers in Bioscience - Elite

Volumn 1 E, Issue 1, 2009, Pages 115-122

  Leask, Andrew ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Connective tissue growth factor; Endothelin; Fibrosis; Review; Scarring

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CTGF PROTEIN, HUMAN; ENDOTHELIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; FIBROSIS; HUMAN; METABOLISM; PHYSIOLOGY; RAT; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS;

ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIN-1; FIBROSIS; HUMANS; RATS; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 77953633610     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Eckes B, Zigrino P, Kessler D, Holtkotter O, Shephard P, Mauch C, Krieg T Fibroblast-matrix interactions in wound healing and fibrosis Matrix Biol. 19:325-32 (2000) (Pubitemid 30665656)
2. Gabbiani G The myofibroblast in wound healing and fibrocontractive diseases J Pathol 200:500-3 (2003) (Pubitemid 36818250)
3. Bedossa P, Paradis V. Liver extracellular matrix in health and disease J Pathol. 200:504-15 (2003) (Pubitemid 36818251)
4. Fogo AB. Mesangial matrix modulation and glomerulosclerosis Exp Nephrol. 7:147-59 (1999) (Pubitemid 29210177)
5. LeRoy EC, Trojanowska MI, Smith EA Cytokines and human fibrosis. Eur Cytokine Netw. 1:215-9 (1990)
6. Chen, Y., Shiwen, X., van Beek, J. Kennedy, L., McLeod, M., Renzoni, E. A., Bou-Gharios, G., Wilcox-Adelman, S., Goetinck, P. F., Eastwood, M., Black, C. M., Abraham, D. J., Leask, A Matrix contraction by dermal fibroblasts requires TGFbeta/ALK5, heparan sulfate containing proteoglycans and MEK/ERK: Insights into pathological scarring in chronic fibrotic disease Am. J. Pathol. 167:1699-1711 (2005) (Pubitemid 41713321)
7. Kane CJ, Hebda PA, Mansbridge JN, Hanawalt PC Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing Cell Physiol. 148:157-73 (1991) (Pubitemid 21910138)
8. McCartney-Francis NL, Frazier-Jessen M, Wahl SM TGF-beta: a balancing act. Int Rev Immunol. 16:553-80 (1998)
9. Massague J. TGF-beta signal transduction. Annu Rev Biochem. 67:753-91 (1998)
10. Leask A, Abraham DJ TGF-beta signaling and the fibrotic response FASEB J. 18:816-27 (2004)
11. Leask A. Scar wars: Is TGFbeta the phantom menace in scleroderma? Arthritis Res. Ther., 8(4):213 (2006)
12. Roberts AB. TGF-beta signaling from receptors to the nucleus Microbes Infect. 1:1265-73 (1999)
13. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern SE Human Smad3 and Smad4 are sequence-specific transcription activators Mol Cell. 1:611-7 (1998) (Pubitemid 128374697)
14. Liu B, Dou CL, Prabhu L, Lai E FAST-2 is a mammalian winged-helix protein which mediates transforming growth factor beta signals Mol Cell Biol. 19:424-30 (1999) (Pubitemid 29018444)
15. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, ten Dijke P Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 389:631-5 (1997) (Pubitemid 27446184)
16. von Gersdorff G, Susztak K, Rezvani F, Bitzer M, Liang D, Bottinger EP. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta. J Biol Chem. 275:11320-6 (2000) (Pubitemid 30212781)
17. McWhirter A, Colosetti P, Rubin K, Miyazono K, Black C Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts. Lab Invest. 71:885-94 (1994)
18. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta Science 237:1333-6 (1987) (Pubitemid 17125439)
19. Lin RY, Sullivan KM, Argenta PA, Meuli M, Lorenz HP, Adzick NS Exogenous transforming growth factorbeta amplifies its own expression and induces scar formation in a model of human fetal skin repair Ann Surg. 222:146-54 (1995)
20. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. Connective tissue growth factor mediates transforming growth factor betainduced collagen synthesis: down-regulation by cAMP. FASEB J. 13:1774-86 (1999) (Pubitemid 29473339)
21. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol. 181:153-9 (1999) (Pubitemid 29400382)
22. Shah M, Foreman DM, Ferguson MW Neutralising antibody to TGF-beta 1, 2 reduces cutaneous scarring in adult rodents. J Cell Sci. 107:1137-57 (1994)
23. Cordeiro MF, Mead A, Ali RR, Alexander RA, Murray S, Chen C, York-Defalco C, Dean NM, Schultz GS, Khaw PT Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome Gene Ther. 10:59-71 (2003) (Pubitemid 36175827)
24. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol. 1:260-6 (1999) (Pubitemid 129495775)
25. Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, Arabshahi A, Major C, Deng C, Russo A, Mitchell JB, Roberts AB Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol. 160:1057-68 (2002) (Pubitemid 34224592)
26. Lakos G, Takagawa S, Chen SJ, Ferreira AM, Han G, Masuda K, Wang XJ, DiPietro LA, Varga J Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol. 165:203-17 (2004) (Pubitemid 38821828)
27. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem. 276:10594-601 (2001) (Pubitemid 38089227)
28. Yang YC, Piek E, Zavadil J, Liang D, Xie D, Heyer J, Pavlidis P, Kucherlapati R, Roberts AB, Bottinger EP Hierarchical model of gene regulation by transforming growth factor beta Proc Natl Acad Sci U S A 100:10269-74 (2003) (Pubitemid 37071868)
29. Verrecchia F, Chu ML, Mauviel A Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem. 276:17058-62 (2001)
30. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest. 112:1486-94 (2003) (Pubitemid 38056275)
31. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, Morishita R, Johnson RJ. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasoundmicrobubble system in rat UUO model. J Am Soc Nephrol. 14:1535-48 (2003) (Pubitemid 36687055)
32. Masaki T, Foti R, Hill PA, Ikezumi Y, Atkins RC, Nikolic-Paterson DJ. Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int. 63:1256-64 (2003) (Pubitemid 36349991)
33. Stambe C, Atkins RC, Tesch GH, Masaki T, Schreiner GF, Nikolic-Paterson DJ. The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol. 15:370-9 (2004) (Pubitemid 38140777)
34. Fu P, Liu F, Su S, Wang W, Huang XR, Entman ML, Schwartz RJ, Wei L, Lan HY. Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice. J Am Soc Nephrol. 17:3105-14 (2006) (Pubitemid 44707770)
35. Moon JA, Kim HT, Cho IS, Sheen YY, Kim DK. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int. 70:1234-43 (2006) (Pubitemid 44435174)
36. de Gouville AC, Boullay V, Krysa G, Pilot J, Brusq JM, Loriolle F, Gauthier JM, Papworth SA, Laroze A, Gellibert F, Huet S. Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br J Pharmacol. 145:166-77 (2005) (Pubitemid 40756521)
37. Bonniaud P, Margetts PJ, Kolb M, Schroeder JA, Kapoun AM, Damm D, Murphy A, Chakravarty S, Dugar S, Higgins L, Protter AA, Gauldie J. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med. 171:889-98 (2005) (Pubitemid 40562720)
38. Abraham DJ, Eckes B, Rajkumar V, Krieg T. New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma. Curr Rheumatol Rep. 9:136-43 (2007) (Pubitemid 46932720)
39. Chen, Y., Shi-wen, X., Eastwood, M., Black, C. M., Denton, C. P., Leask, A, Abraham D. J. ALK5 (TGFß receptor type I) signaling contributes to the fibrotic phenotype of scleroderma fibroblasts. Arthr. Rheum. 54:1309-1316 (2006)
40. Mori Y, Chen SJ, Varga J. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts. Arthritis Rheum. 48:1964-78 (2003) (Pubitemid 36828692)
41. Pannu J, Gore-Hyer E, Yamanaka M, Smith EA, Rubinchik S, Dong JY, Jablonska S, Blaszczyk M, Trojanowska M. An increased transforming growth factor beta receptor type I: type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma. Arthritis Rheum. 50:1566-77 (2004) (Pubitemid 38608079)
42. Denton CP, Merkel PA, Furst DE, Khanna D, Emery P, Hsu VM, Silliman N, Streisand J, Powell J, Akesson A, Coppock J, Hoogen F, Herrick A, Mayes MD, Veale D, Haas J, Ledbetter S, Korn JH, Black CM, Seibold JR; Cat-192 Study Group; Scleroderma Clinical Trials Consortium. Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum. 56:323-33 (2007) (Pubitemid 46106206)
43. Leask A. TGFbeta in cardiac fibrosis. Cardiovasc. Res. 74:207-12 (2007)
44. Santander C, Brandan E. Betaglycan induces TGFbeta signaling in a ligand-independent manner, through activation of the p38 pathway. Cell Signal. 18:1482-91 (2006) (Pubitemid 43832084)
45. Liu, S., Shi-wen, X., Kennedy, L., Pala, D., Carter, DE, Black, CM, Abraham, DJ, Leask, A. FAK is required for TGFbeta-induced JNK phosphorylation in fibroblasts: implications for acquisition of a matrix remodeling phenotype. Mol. Biol. Cell. 18:2169-2178 (2007) (Pubitemid 46911368)
46. Thannickal VJ, Lee DY, White ES, Cui Z, Larios JM, Chacon R, Horowitz JC, Day RM, Thomas PE Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase J Biol Chem. 278:12384-9 (2003) (Pubitemid 36800223)
47. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int. 62:1149-59 (2002)
48. Leask, A, Holmes, A., Black, CM, Abraham, D. J. CTGF gene regulation: requirements for its induction by TGFbeta in fibroblasts. J. Biol. Chem. 278, 13008-15 (2003)
49. Stratton R, Rajkumar V, Ponticos M, Nichols B, Shiwen X, Black CM, Abraham DJ, Leask A Prostacyclin derivatives prevent the fibrotic response to TGF-beta by inhibiting the Ras/MEK/ERK pathway FASEB J. 16:1949-51 (2002)
50. Hayashida T, Wu MH, Pierce A, Poncelet AC, Varga J, Schnaper HW. MAP-kinase activity necessary for TGFbeta1-stimulated mesangial cell type I collagen expression requires adhesion-dependent phosphorylation of FAK tyrosine 397. J Cell Sci. 120:4230-40 (2007)
51. Shi-wen, X., Rodrigues-Pascual, F., Lamas, S., Holmes, A., Howat, S., Pearson, J. D., Dashwood, MR., du Bois, RM, Denton, CP, Black, CM, Abraham, DJ, Leask A Constitutive ALK5-indepenent JNK activation contributes to endothelin-1 over-expression in pulmonary fibrosis. Mol Cell Biol. 26:5518-27 (2006)
52. Shi-Wen X, Chen Y, Denton CP, Eastwood M, Renzoni EA, Bou-Gharios G, Pearson JD, Dashwood M, du Bois RM, Black CM, Leask A, Abraham DJ. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts Mol Biol Cell. 15:2707-19 (2004) (Pubitemid 38691860)
53. Shi-wen X., Howat SL, Renzoni EA, Holmes A, Pearson JD, Dashwood MR, Bou-Gharios G, Denton CP, du Bois RM, Black CM, Leask A, Abraham DJ. Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J Biol Chem. 279:23098-103 (2004) (Pubitemid 38685614)
54. Denton CP, Pope JE, Peter HH, Gabrielli A, Boonstra A, van den Hoogen FH, Riemekasten G, De Vita S, Morganti A, Berkani O, Guillevin L. Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases. Ann Rheum Dis. doi:10.1136/ard.2007.079921 (2007)
55. Castanares C, Redondo-Horcajo M, Magan-Marchal N, ten Dijke P, Lamas S, Rodriguez-Pascual F. Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation. J Cell Sci. 120:1256-66 (2007) (Pubitemid 46711844)
56. Shi-wen, X., Kennedy, L., Renzoni, E., du Bois, R., Denton, C., Black, C., Abraham, D., Leask A. Endothelin-1 is a downstream mediator of the profibrotic effects of TGFbeta in fibroblasts. Arthritis Rheum, 56:4189-94 (2007) (Pubitemid 350262347)
57. Shephard P, Hinz B, Smola-Hess S, Meister JJ, Krieg T, Smola H. Dissecting the roles of endothelin, TGF-beta and GM-CSF on myofibroblast differentiation by keratinocytes. Thromb Haemost. 92:262-74 (2004) (Pubitemid 39172306)
58. Horstmeyer A, Licht C, Scherr G, Eckes B, Krieg T. Signalling and regulation of collagen I synthesis by ET-1 and TGF-beta1 FEBS J. 272:6297-309 (2005) (Pubitemid 41815618)
59. Shi-wen, X., Renzoni, EA, Kennedy, L., Howat, S, Chen, Y, Pearson, JD Bou-Gharios, G, Dashwood, MR, du Bois, RM, Black, CM, Denton, CP, Abraham, DJ, Leask, A. Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts. Matrix Biol. 26:625-32 (2007) (Pubitemid 350186096)
60. Leask A Abraham DJ. All in the CCN family: essential signaling mediators emerge from the bunker. J. Cell Sci. 119:4803-10 (2006) (Pubitemid 46017793)
61. Van Beek JP, Kennedy L, Rockel JS, Bernier SM, Leask A The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther. 8:R36 (2006)
62. Dziadzio M, Usinger W, Leask A, Abraham D, Black CM, Denton C, Stratton R N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. QJM. 98:485-92 (2005) (Pubitemid 41418671)
63. Okada H, Kikuta T, Kobayashi T, Inoue T, Kanno Y, Takigawa M, Sugaya T, Kopp JB, Suzuki H. Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol. 16:133-43 (2005) (Pubitemid 43073165)
64. Uchio K, Graham M, Dean NM, Rosenbaum J, Desmouliere A. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis. Wound Repair Regen. 12:60-6 (2004) (Pubitemid 38249137)
65. Lang C, Sauter M, Szalay G, Racchi G, Grassi G, Rainaldi G, Mercatanti A, Lang F, Kandolf R, Klingel K. Connective tissue growth factor: a crucial cytokinemediating cardiac fibrosis in ongoing enterovirus myocarditis. J Mol Med. 86:49-60 (2008)
66. Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J, Kolb M. Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosisresistant" BALB/c mouse lungs. Am J Respir Cell Mol Biol. 31:510-6 (2004) (Pubitemid 39463399)
67. Bonniaud P, Margetts PJ, Kolb M, Haberberger T, Kelly M, Robertson J, Gauldie J. Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. Am J Respir Crit Care Med. 168:770-8 (2003) (Pubitemid 37188299)
68. Shi-Wen X, Stanton L, Kennedy L, Pala D, Chen Y, Howat SL, Renzoni EA, Carter DE, Bou-Gharios G, Stratton R, Pearson JD, Beier F, Lyons KM, Black CM, Abraham DJ, Leask A CCN2 is necessary for adhesive responses to TGFbeta 1 in embryonic fibroblasts J Biol Chem. 281:10715-26 (2006) (Pubitemid 43855493)
69. Chen Y, Abraham DJ, Shi-Wen X, Pearson JD, Black CM, Lyons KM, Leask A. CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell. 15:5635-46 (2004) (Pubitemid 39564754)
70. Babic AM, Chen CC, Lau LF. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol. 19:2958-66 (1999) (Pubitemid 29144541)
71. Gao R, Brigstock DR. Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha (v) beta (3) and heparan sulfate proteoglycan. J Biol Chem. 279:8848-55 (2004) (Pubitemid 38295943)
72. Kennedy, L., Liu, S., Shi-wen, X., Carter, D., Lyons, K., Black, C. M., Abraham, D. J, Leask A. CCN2 is essential for fibroblast function. Exp. Cell Res 313:952-964 (2007)